These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16076818)

  • 1. Vaccination boosts adult immunity to varicella zoster virus.
    Weir E
    CMAJ; 2005 Aug; 173(3):249. PubMed ID: 16076818
    [No Abstract]   [Full Text] [Related]  

  • 2. Live attenuated varicella vaccine for prevention of herpes zoster.
    Gershon A; Silverstein S
    Biologicals; 1997 Jun; 25(2):227-30. PubMed ID: 9236057
    [No Abstract]   [Full Text] [Related]  

  • 3. Varicella immunization and herpes zoster.
    Volpi A
    Herpes; 2005 Dec; 12(3):59. PubMed ID: 16393520
    [No Abstract]   [Full Text] [Related]  

  • 4. Herpes zoster and postherpetic neuralgia: prevention and management.
    Mounsey AL; Matthew LG; Slawson DC
    Am Fam Physician; 2005 Sep; 72(6):1075-80. PubMed ID: 16190505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study tests Varicella-Zoster vaccine for over 60-years-old persons. Protection from Herpes zoster and postherpetic neuralgia].
    MMW Fortschr Med; 2006; Spec no.1():14-5. PubMed ID: 16872127
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
    Betts RF
    J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of shingles by varicella zoster virus vaccination.
    Holodniy M
    Expert Rev Vaccines; 2006 Aug; 5(4):431-43. PubMed ID: 16989624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity.
    Levin MJ; Schmader K
    Herpes; 2007 Sep; 14 Suppl 2():45-7. PubMed ID: 17939896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Varicella vaccine].
    Abarca Villaseca K
    Rev Chilena Infectol; 2006 Mar; 23(1):56-9. PubMed ID: 16462966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of varicella and zoster in British Columbia 1994-2003: baseline assessment prior to universal vaccination.
    Edgar BL; Galanis E; Kay C; Skowronski D; Naus M; Patrick D
    Can Commun Dis Rep; 2007 Nov; 33(11):1-15. PubMed ID: 18163240
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
    Holcomb K; Weinberg JM
    J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.
    Reynolds MA; Chaves SS; Harpaz R; Lopez AS; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S224-7. PubMed ID: 18419401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varicella-zoster virus vaccine--grown-ups need it, too.
    Gilden DH
    N Engl J Med; 2005 Jun; 352(22):2344-6. PubMed ID: 15930426
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of herpes zoster and its painful and debilitating complications.
    Johnson R; McElhaney J; Pedalino B; Levin M
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S43-8. PubMed ID: 18162246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
    Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella zoster vaccines.
    Creed R; Satyaprakash A; Ravanfar P
    Dermatol Ther; 2009; 22(2):143-9. PubMed ID: 19335725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-herpetic neuralgia: a review of advances in treatment and prevention.
    Young L
    J Drugs Dermatol; 2006; 5(10):938-41. PubMed ID: 17373141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
    Goldman GS
    Int J Toxicol; 2005; 24(4):205-13. PubMed ID: 16126614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
    de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
    Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence.
    Oxman MN
    J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S13-7. PubMed ID: 19553630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.